Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCalidi Biotherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Calidi Biotherapeutics, Inc.

$1.04Close · Oct 8, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q4 ’222022202420252026-6M-4M-2M0Latest period Q4 '22. Revenue 0. Gross profit 0. Net profit -7.76M.
RevenueGross profitNet profit
See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
Q4 ’2220222024202520260%0%0%0%0%Latest period Q4 '22. No revenue — margins undefined.
Gross marginOperating marginNet profit marginNo revenue (margins undefined)
Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
$
Q2 ’2620222023202420252026-12M-10M-8M-6M-4M-2M0
      Latest period Q2 '26. Operating cash flow -4.4M.
      Operating cash flowCapexFree cash flow
      Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
      20262022202320242025202602M4M6M8M10M
          Latest period 2026. Cash 4.1M. Debt 45K.
          CashDebtNet cash
          Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
          $/share
          Q2 ’2620222023202420252026-15,000.00-10,000.00-5,000.000.00
            • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 23,000,000 source shares.
            • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-06-30: 23,000,000 source shares.
            • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 4,128,024 source shares.
            • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 8,583,724 source shares.
            • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 5,750,000 source shares.
            • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 5,750,000 source shares.
            • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 35,436,000 source shares.
            • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 3,552,223 source shares.
            • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 35,726,784 source shares.
            • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 6,469,115 source shares.
            • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 9,310,522 source shares.
            • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 1,730,051 source shares.
            • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 31,792,580 source shares.
            • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 2,876,757 source shares.
            • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 6,906,312 source shares.
            • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 451,076 source shares.
            • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 11,786,725 source shares.
            • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 2,082,648 source shares.
            Latest period Q2 2026. EPS (TTM) -180.19.
            EPS (TTM)
            How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
            Q2 ’26202220232024202520260x20x40x60x80x
              • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 23,000,000 source shares. Nearby weekly price on 2022-04-01.
              • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-06-30: 23,000,000 source shares. Weekly price on 2022-06-30.
              • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 4,128,024 source shares. Weekly price on 2022-09-30.
              • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 8,583,724 source shares. Nearby weekly price on 2022-12-30.
              • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 5,750,000 source shares. Weekly price on 2023-03-31.
              • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 5,750,000 source shares. Weekly price on 2023-06-30.
              • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 35,436,000 source shares. Nearby weekly price on 2023-09-29.
              • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 3,552,223 source shares. Nearby weekly price on 2023-12-29.
              • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 35,726,784 source shares. Nearby weekly price on 2024-03-28.
              • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 6,469,115 source shares. Nearby weekly price on 2024-06-28.
              • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 9,310,522 source shares. Nearby weekly price on 2024-09-27.
              • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 1,730,051 source shares. Nearby weekly price on 2025-01-03.
              • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 31,792,580 source shares. Nearby weekly price on 2025-03-28.
              • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 2,876,757 source shares. Nearby weekly price on 2025-06-27.
              • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 6,906,312 source shares. Nearby weekly price on 2025-10-03.
              • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 451,076 source shares. Nearby weekly price on 2026-01-02.
              • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 11,786,725 source shares. Nearby weekly price on 2026-04-02.
              • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 2,082,648 source shares. Nearby weekly price on 2026-07-02.
              Latest period Q2 2026. P/E ratio -0x.
              P/E ratio
              See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
              202620222023202420252026010M20M30M
              2024-07-15: Reverse stock split 1-for-10
              2025-08-05: Reverse stock split 1-for-12
                  Latest period 2026. Shares outstanding 2.1M. Class detail unavailable 2.1M.
                  Class detail unavailableStock split